Edesa Biotech, Inc.
EDSA
$4.72
-$0.01-0.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -138.24% | -78.90% | -27.94% | -16.46% | 14.56% |
| Total Depreciation and Amortization | -25.22% | -36.83% | -44.76% | -35.86% | -26.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 338.14% | 317.48% | 149.92% | 39.60% | -55.68% |
| Change in Net Operating Assets | 369.94% | 436.73% | -343.19% | -272.61% | -398.91% |
| Cash from Operations | -35.61% | -31.48% | -57.82% | -49.73% | -21.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -3.72% | -51.30% | 917.17% | 958.09% | 517.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | 441.28% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 57.78% | 68.96% | -215.95% | -426.44% | -282.46% |
| Cash from Financing | -58.49% | -79.12% | 676.77% | 2,776.84% | 1,523.03% |
| Foreign Exchange rate Adjustments | -233.25% | 201.84% | 207.50% | 278.38% | 224.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.66% | -135.08% | 487.83% | 325.59% | 333.70% |